如何提高慢性心力衰竭患者的心脏效益?
Toshihide Izumida1,2, Koichiro Kinugawa1
1Second Department of Internal Medicine, University of Toyama, Toyama, Japan.
International journal of heart failure
|June 16, 2025
概括
在慢性病患者中,新的心力衰竭药物为心脏和脏提供双重保护. 这些先进的疗法改善了结果,并减缓了功能下降,特别是在糖尿病患者中.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性心力衰竭 (CHF) 和慢性病 (CKD) 经常同时存在,使管理复杂化,结果恶化.
- 由于标准治疗的限制和剂量调整,在晚期CKD中管理CHF具有挑战性.
- 在疾病的早期阶段,心血管保护至关重要.
研究的目的:
- 审查最近心力衰竭药物治疗方面的进展.
- 强调新药的心脏脏保护机制和临床疗效.
- 突出个性化疗法的重要性,以获得最佳的心脏和脏效益.
主要方法:
- 关于治疗心血管疾病和慢性脏病的新型药物治疗的当前文献的综述.
- 分析特定药物类别所提供的心脏脏保护机制.
- 对临床试验数据的有效性和安全性的评估.
主要成果:
- 像ARNI,SGLT2抑制剂,MRA和GLP-1RA等新型药物显示出双重心脏脏保护作用.
- 这些疗法可以降低心力衰竭的风险,改善心脏不全的结果,并减缓CKD的进展.
- 糖尿病患者,白性CKD和CHF患者的好处尤其显著,尽管可能有暂时的GFR下降.
结论:
- 先进的药物疗法在患有同时存在心肺炎和慢性病的患者中提供了显著的心保护.
- 个性化治疗策略对于最大限度地提高益处并最大限度地减少不良影响至关重要.
- 需要进一步的研究来弥合知识差距并优化治疗方法.
更多相关视频
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
526
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
526
Heart Failure Drugs: Diuretics
505
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
505
Heart Failure V: Medical Management
34
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
34
Heart Failure VI: Adjunct Therapies
39
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
39
Heart Failure VII: Nursing Interventions
147
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
147
Chronic Kidney Disease IV: Nursing Management
62
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
62


